Korean Cancer Association

Invited Speakers

Plenary Lectures (PL)
Special Lecture (SL)
Educational Sessions (ES)
Young Investigator Symposium (YIS)
Symposia (SP)
Master Class (MC)
Satellite Symposium (SS)

Plenary Lectures

Peter Campbell, Ph.D	cv
Wellcome Trust Sanger Institute, UK Interrogating the architecture of cancer genomes

Frank McCormick, Ph.D., F.R.S.	cv
Professor, UCSF Helen Diller Family Comprehensive Cancer Center, USA New ways of targeting K-Ras

Dong-Young Noh, M.D., Ph.D.	cv
Professor, Department of Surgery, Seoul National University College of Medicine, Korea Translational research in surgical oncology

Ho-Young Lee, Ph.D.	cv
Professor, Seoul National University College of Pharmacy, Korea Key strategies to overcome anticancer drug resistance in non-small cell lung cancer

Special Lecture

Anindya Dutta, M.D., Ph.D.	cv
Professor, University of Virginia School of Medicine, USA MicroDNA: Discovery of extrachromosomal circles of DNA and their roles in cancer

Educational Sessions

ES1. Foundation of precision oncology

6/21(Thu) 09:00-10:40

Jung Kyoon Choi

Korea Advanced Institute of Science and Technology (KAIST)

Jong-Il Kim

Seoul National University College of Medicine

Hyun Goo Woo

Ajou University School of Medicine

Jeeyun Lee

Sungkyunkwan University School of Medicine

ES2. Progress in surgical treatment for malignant disease

6/21(Thu) 09:00-10:40

Hyuk-Joon Lee

Seoul National University College of Medicine

Ki-Hun Kim

University of Ulsan College of Medicine

Jeong Eon Lee

Sungkyunkwan University School of Medicine

Gyu-Seog Choi

Kyungpook National University School of Medicine

ES3. Genomic and immuno-oncology era in radiation oncology

6/21(Thu) 13:20-15:00

O Kyu Noh

Ajou University School of Medicine

In Ah Kim

Seoul National University College of Medicine

Si Yeol Song

University of Ulsan College of Medicine

Wonil Jang

Korea Institute of Radiological & Medical Sciences

Young Investigator Symposium

Eunhee Kim

Ulsan National Institute of Science and Technology (UNIST)

Jisun Kim

University of Ulsan College of Medicine

Young Seok Ju

Korea Advanced Institute of Science and Technology (KAIST)

Yul Hwangbo

National Cancer Center

Symposia (SP)

SP01. Emerging molecular segments in gastrointestinal cancer

6/21(Thu) 09:00-10:40

Daniel Catenacci

University of Chicago, USA

Keun-Wook Lee

Seoul National University Bundang Hospital

Taroh Satoh

Osaka University Graduate School of Medicine, Japan

SP02. Clinical trials and molecular imaging biomarkers

6/21(Thu) 09:00-10:40

Richard Leo Wahl

Washington University School of Medicine in St. Louis, USA

Joo Hyun O

The Catholic University of Korea College of Medicine

Joon Young Choi

Sungkyunkwan University School of Medicine

Seunggyun Ha

Seoul National University College of Medicine

SP03. Plasma genotyping for precision medicine

6/21(Thu) 13:20-15:00

Jong-Won Kim

Sungkyunkwan University School of Medicine

Kyung A Lee

Yonsei University College of Medicine

Sun-Young Kong

National Cancer Center

Eunhae Cho

Green Cross Genome

SP04. Change of surgical strategy by multidisciplinary treatment

6/21(Thu) 13:20-15:00

Kyu-pyo Kim

University of Ulsan College of Medicine

Kil Yeon Lee

Kyung Hee University School of Medicine

Oh Jeong

Chonnam National University Medical School

Eun Sook Lee

National Cancer Center

SP05. Key issues in biosimilars

6/21(Thu) 13:20-15:00

HoUng Kim

Celltrion Healthcare, Co., Ltd.

Jong Won Kim

NIFDS/MFDS

In Hae Park

National Cancer Center

Tae-Yong Kim

Seoul National University Hospital

SP06. Multifocal lung cancer: The same or different?
Aggressive or conservative?

6/21(Thu) 13:20-15:00

Hyae Young Kim

National Cancer Center

Hyojin Kim

Seoul National University Bundang Hospital

Sehoon Choi

University of Ulsan College of Medicine

Min Hee Hong

Yonsei University College of Medicine

SP07. Recent progress in cancer epigenomics

6/21(Thu) 13:20-15:00

Gyeong Hoon Kang

Seoul National University College of Medicine

Kyung Hyun Ryu

Sookmyung Women's University

Myunggon Ko

Ulsan National Institute of Science and Technology (UNIST)

So Hee Kwon

Yonsei University College of Pharmacy

SP08. Microenvironment and tumorigenesis 1

6/21(Thu) 13:20-15:00

Yu Gan

Shanghai Cancer Institute, China

Wei-Qiang Gao

Shanghai Cancer Institute, China

Kang-Yell Choi

Yonsei University College of Life Science and Biotechnology

Young Il Yeom

Korea Research Institute of Bioscience & Biotechnology (KRIBB)

SP09. Personalized cancer immunotherapy

6/21(Thu) 15:20-17:00

Se-Ho Park

Korea University

Hansoo Park

Gwangju Institute of Science and Technology (GIST)

Shinichi Makita

National Cancer Center Hospital, Japan

Sangwoo Kim

Yonsei University College of Medicine

SP10. Hospice and palliative care

6/21(Thu) 15:20-17:00

Yoon-Jung Chang

National Cancer Center

Jung Hye Kwon

Kangdong Sacred Heart Hospital

Su-jin Koh

Ulsan University Hospital

SP11. Genomic alterations in premalignant lesions

6/21(Thu) 15:20-17:00

Kyoung-Mee Kim

Sungkyunkwan University School of Medicine

Young Nyun Park

Yonsei University College of Medicine

Hyo Sup Shim

Yonsei University College of Medicine

Jung Ho Kim

Seoul National University Hospital

SP12. Bio-medical research using big accelerators

6/21(Thu) 15:20-17:00

Jae-Hong Lim

Pohang Accelerator Laboratory

Kye Ryung Kim

Korea Atomic Energy Research Institute (KAERI)

Young Kwan Kwon

Institute for Basic Science (IBS)

Sei Sai

National Institutes for Quantum and Radiological Science and Technology, Japan

SP13. Optimization of adjuvant systemic treatment for EBC

6/21(Thu) 15:20-17:00

Edith Perez

Mayo Clinic, USA

Jee Hyun Kim

Seoul National University Bundang Hospital

Keun Seok Lee

National Cancer Center

Joohyuk Sohn

Yonsei University College of Medicine

SP14. Microenvironment and tumorigenesis 2

6/21(Thu) 15:20-17:00

Zhi-Gang Zhang

Shanghai Cancer Institute, China

Guanglei Zhuang

Shanghai Cancer Institute, China

WanKyu Kim

Ewha Womans University

Hyuk-Jin Cha

Seoul National University College of Pharmacy

SP15. Promising anti-cancer drug pipeline in pre-clinical and
clinical stages in Korea

6/22(Fri) 13:40-15:20

Young-Whan Park

National OncoVenture

Jeeyun Lee

Sungkyunkwan University School of Medicine

Kee-Won Kim

CKD Pharm.

Jinhyung Ahn

ABL Bio Inc.

SP16. Tailored care for young women with cancer

6/22(Fri) 13:40-15:20

Yeon Hee Park

Sungkyunkwan University School of Medicine

Ji Soo Park

Yonsei Cancer Center

Jayeon Kim

CHA University School of Medicine

Woo Kyung Moon

Seoul National University College of Medicine

SP17. Recent updates and future perspectives
on the hepato-biliary cancer

6/22(Fri) 13:40-15:20

Ahmed Kaseb

MD Anderson Cancer Center, USA

Masafumi Ikeda

National Cancer Center Hospital East, Japan

Do-Youn Oh

Seoul National University College of Medicine

SP18. Current debate in the oncologic management of rectal cancer

6/22(Fri) 13:40-15:20

Hyung Jin Kim

The Catholic University of Korea College of Medicine

Se-Jin Baek

Korea University College of Medicine

Seung Hyun Cho

Kyungpook National University School of Medicine

Soo Yeun Park

Kyungpook National University School of Medicine

SP19. Multi-omics approaches in cancer research

6/22(Fri) 13:40-15:20

Hyun Seok Kim

Yonsei University College of Medicine

Yong Sun Lee

National Cancer Center

Youngsoo Kim

Seoul National University College of Medicine

Hak Kyun Kim

Stanford University, USA

SP20. From scientific lead to companion diagnostics (CDx)
approval process in Korea

6/22(Fri) 15:40-17:20

Jee-Eun Kim

Gencurix Inc.

Jihun Kim

University of Ulsan College of Medicine

Kwang Joong Kim

NGeneBio

Kyoung-Mee Kim

Sungkyunkwan University School of Medicine

SP21. Multidisciplinary care of BRCA mutation carriers

6/22(Fri) 15:40-17:20

Han-Byoel Lee

Seoul National University Hospital

Sang-Ah Han

Kyung Hee University School of Medicine

Myong Cheol Lim

National Cancer Center

Yong Wha Moon

CHA University School of Medicine

SP22. Update of gastric cancer research in Korea

6/22(Fri) 15:40-17:20

Young-Woo Kim

National Cancer Center

Do-Youn Oh

Seoul National University College of Medicine

Yoon-Koo Kang

University of Ulsan College of Medicine

Il Ju Choi

National Cancer Center

SP23. Tumor immunity and immunotherapy

6/22(Fri) 15:40-17:20

Lihui Zou

Beijing Medical Association, China

Xundong Wei

Biotherapy Center, Beijing Hospital, China

Byoung Chul Cho

Yonsei University College of Medicine

Chang-Yuil Kang

Seoul National University College of Pharmacy

Master Class (MC)

MC1. Time-traveling in the IO space: Investigate the current status
and foresight the IO space

6/21(Thu) 09:00-10:40

Byoung Chul Cho

Yonsei University College of Medicine

Andrey Loboda

MSD, USA

Michael Holmes

MSD, USA

MC2. Evaluating current and emerging strategies using
checkpoint inhibitors: Where are we now and where are we going?

6/21(Thu) 13:20-15:00

Kiyoshi Hashigami

Bristol-Myers Squibb K.K., Japan

Ji-Youn Han

National Cancer Center

Ross Soo

National University Cancer Institute, Singapore

MC3. Towards precision healthcare: Overcoming the challenges of
NGS-based cancer profiling

6/21(Thu) 15:20-17:00

Sangwoo Kim

Yonsei University College of Medicine

Yoon-La Choi

Sungkyunkwan University School of Medicine

Kyu-pyo Kim

University of Ulsan College of Medicine

MC4. A forum on tumor microenvironment

6/22(Fri) 13:40-15:20

Mariusz Lukanowski

Lilly, Denmark

Taroh Satoh

Osaka University Graduate School of Medicine, Japan

Satellite Symposium (SS)

Satellite Symposium 1 (by MSD)

6/21(Thu) 12:20-13:20

Ji-Youn Han	cv
National Cancer Center The art of immunotherapy in NSCLC

Satellite Symposium 2 (by ONO/BMS)

6/21(Thu) 12:20-13:20

Min-Hee Ryu	cv
University of Ulsan College of Medicine Emerging horizons in gastric cancer immunotherapy

Satellite Symposium 3 (by Novartis)

6/21(Thu) 12:20-13:20

Byoung Chul Cho	cv
Yonsei University College of Medicine Ceritinib: How to optimize treatment of ALK + NSCLC in 1L

Satellite Symposium 4 (by Roche)

6/22(Fri) 11:50-12:50

Harald A. Weber	cv
Roche, Singapore Harnessing the power of immunotherapy and targeted therapy in lung cancer

Satellite Symposium 5 (by Lilly)

6/22(Fri) 11:50-12:50

Taroh Satoh	cv
Osaka University Graduate School of Medicine, Japan Current status and real world experience of anti-angiogenesis in Advanced Gastric Cancer

Satellite Symposium 6 (by Pfizer)

6/22(Fri) 11:50-12:50

Yasushi Goto	cv
National Cancer Center Hospital, Japan Reassuring the absolute survival benefit of ALK sequential therapy and the value of First-in-class ROS1 inhibitor

top